Sweep FC - Search Results

1

Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.

Liu NQ, De Marchi T, Timmermans AM, Beekhof R, Trapman-Jansen AM, Foekens R, Look MP, van Deurzen CH, Span PN, Sweep FC, Brask JB, Timmermans-Wielenga V, Debets R, Martens JW, Foekens JA, Umar A. Liu NQ, et al. Among authors: sweep fc. Mol Cell Proteomics. 2014 Jul;13(7):1814-27. doi: 10.1074/mcp.M113.037176. Epub 2014 Apr 17. Mol Cell Proteomics. 2014. PMID: 24742827 Free PMC article.

2

Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.

Berns EM, Klijn JG, Look MP, Grebenchtchikov N, Vossen R, Peters H, Geurts-Moespot A, Portengen H, van Staveren IL, Meijer-van Gelder ME, Bakker B, Sweep FC, Foekens JA. Berns EM, et al. Among authors: sweep fc. Clin Cancer Res. 2003 Apr;9(4):1253-8. Clin Cancer Res. 2003. PMID: 12684392

3

Tumor markers: from laboratory to clinical utility.

Schrohl AS, Holten-Andersen M, Sweep F, Schmitt M, Harbeck N, Foekens J, Brünner N; European Organisation for Research and Treatment of Cancer (EORTC) Receptor and Biomarker Group. Schrohl AS, et al. Mol Cell Proteomics. 2003 Jun;2(6):378-87. doi: 10.1074/mcp.R300006-MCP200. Epub 2003 Jun 17. Mol Cell Proteomics. 2003. PMID: 12813140 Free article. Review. No abstract available.

4

Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.

Manders P, Sweep FC, Tjan-Heijnen VC, Geurts-Moespot A, van Tienoven DT, Foekens JA, Span PN, Bussink J, Beex LV. Manders P, et al. Among authors: sweep fc. Clin Cancer Res. 2003 Dec 15;9(17):6363-70. Clin Cancer Res. 2003. PMID: 14695136

5

Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.

Span PN, Waanders E, Manders P, Heuvel JJ, Foekens JA, Watson MA, Beex LV, Sweep FC. Span PN, et al. Among authors: sweep fc. J Clin Oncol. 2004 Feb 15;22(4):691-8. doi: 10.1200/JCO.2004.01.072. J Clin Oncol. 2004. PMID: 14966093

6

The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer.

Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Geurts-Moespot AJ, van Tienoven DT, Beex LV, Sweep FC. Manders P, et al. Among authors: sweep fc. Thromb Haemost. 2004 Mar;91(3):514-21. doi: 10.1160/TH03-07-0467. Thromb Haemost. 2004. PMID: 14983227

7

Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.

Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Geurts-Moespot A, van Tienoven DT, Beex LV, Sweep FC. Manders P, et al. Among authors: sweep fc. Cancer. 2004 Aug 1;101(3):486-94. doi: 10.1002/cncr.20374. Cancer. 2004. PMID: 15274061 Free article.

8

Survivin is an independent prognostic marker for risk stratification of breast cancer patients.

Span PN, Sweep FC, Wiegerinck ET, Tjan-Heijnen VC, Manders P, Beex LV, de Kok JB. Span PN, et al. Among authors: sweep fc. Clin Chem. 2004 Nov;50(11):1986-93. doi: 10.1373/clinchem.2004.039149. Epub 2004 Sep 13. Clin Chem. 2004. PMID: 15364883

9

The prognostic value of BCAR1 in patients with primary breast cancer.

Dorssers LC, Grebenchtchikov N, Brinkman A, Look MP, van Broekhoven SP, de Jong D, Peters HA, Portengen H, Meijer-van Gelder ME, Klijn JG, van Tienoven DT, Geurts-Moespot A, Span PN, Foekens JA, Sweep FC. Dorssers LC, et al. Among authors: sweep fc. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6194-202. doi: 10.1158/1078-0432.CCR-04-0444. Clin Cancer Res. 2004. PMID: 15448007

10

Concerns about mammaglobin assays.

Span PN, Grebenchtchikov NI, Geurts-Moespot A, Sweep FC. Span PN, et al. Among authors: sweep fc. Clin Chem. 2005 Feb;51(2):474-5. doi: 10.1373/clinchem.2004.043331. Clin Chem. 2005. PMID: 15681567 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

315 results

Search Page